Ciproflo-dexa 7.5ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9RB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,453
Award facts
- Contract value 100% obligated
- $10,452.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,452.50 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of CIPROFLO-DEXA 7.5ML, a ciprofloxacin-dexamethasone ophthalmic solution. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and no set-aside designation was utilized. The work will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The company has an extensive track record of competitively awarded contracts with the DLA covering a broad spectrum of medications and medical commodities across multiple therapeutic domains. This delivery order represents one of numerous task orders issued under the parent company's comprehensive global pharmaceutical support vehicle, which enables the supply of brand-name and generic drugs, vaccines, specialty medications, and related healthcare commodities to support military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FW9RB?
SPE2DR26FW9RB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FW9RB worth?
The government has obligated $10,453 on SPE2DR26FW9RB.
Is contract SPE2DR26FW9RB an order under another contract?
Yes. SPE2DR26FW9RB is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9RB competed?
The extent of competition for SPE2DR26FW9RB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award